MED DISCOVERY SA
Route de la Corniche 4
1066 Epalinges - Switzerland
Tél +41 21 566 14 12
Claude Blum obtained his Dr. iur. at Zürich University Law School, he then received a Master of Comparative Law from Southern Methodist University Law School, Dallas, Tx, he was admitted to the Bar in Zürich in 1984. He is a partner with Blum&Grob Attorneys at Law Zurich/Switzerland.
Main founder of Med Discovery in 2002 and its CEO and president until 2011. Dr. Deperthes obtained his Ph.D. in molecular biology in 1996. He has worked as 'Research Unit Head' of the urology unit of the Lausanne University hospital (CHUV) for five years. He then founded and managed the Swiss Biotech Company Med Discovery SA, Geneva, and its spin-out Dermadis, specialized in Dermatology. He has acquired strong experience in technology valorization encompassing patent application, IP strategy and in-/out-licensing from/to worldwide universities or large pharmaceutical companies. Dr Deperthes is also an expert for WIPO (World Intellectual Property Organization) and acts as jury for several entrepreneurship foundations. In 2012 he joined the Swiss biopharmaceutical development company Debiopharm SA, Lausanne, Switzerland as Director Business Development & Licensing.
Professor Adriano Fontana, is a graduate from the University of Zürich (1976) where he currently is Prof. Ordinarius of Clinical Immunology and Director of the Immunology Clinic of the University Hospital. A specialist of immunology of the central nervous system, he authored more than 220 original scientific publications. Member of various Editorial and Foundation Boards he received several prices for his outstanding scientific work. He also hold 3 international patents.
Manfred Heule is the CEO and owner of a tax- and business-consulting company in Zurich. As a former partner of one of the “big five” audit companies, a former extraordinary member of a cantonal tax appeal commission and a member of the International Fiscal Association (IFA) he has a wide experience in accounting, finances and taxes.
Dr. De Serres holds a MD and M.Sc from University of Montreal and a MBA in bioindustries from UQAM. At the beginning of his carreer, he practiced medicine and was Director of teaching unit at McGill University as well as President of the Quebec College of Family Physicians. He has also acted as Director of Public Health in Hull, QC prior to joining Aventis Behring Canada as Medical Director and then as General Manager. He then joined Draximage (a division of Draxis Specialty Pharmaceuticals Inc) as VP Clinical Research and Regulatory Affairs . In 2011 Dr. De Serres was appointed president and CEO of Héma-Québec.